Patient-Reported Outcomes of Maxillary Edentulous Patients Wearing Overdentures Retained by Two Implants from Insertion to 4 Years

被引:5
作者
Zembic, Anja [1 ,2 ]
Tahmaseb, Ali [1 ]
Jung, Ronald E. [2 ]
Wiedemeier, Daniel [3 ]
Wismeijer, Daniel [1 ]
机构
[1] Acad Ctr Dent Amsterdam ACTA, Dept Oral Implantol & Prosthet Dent, Amsterdam, Netherlands
[2] Univ Zurich, Ctr Dent Med, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Plattenstr 11, CH-8032 Zurich, Switzerland
[3] Univ Zurich, Ctr Dent Med, Stat Serv, Zurich, Switzerland
关键词
dental implants; dental prosthesis; edentulous; implant-supported; jaw; maxilla; overdenture; patient-reported outcomes; patient satisfaction; quality of life; QUALITY-OF-LIFE; HEALTH IMPACT PROFILE; SUPPORTED OVERDENTURES; MANDIBULAR OVERDENTURES; PATIENTS SATISFACTION; COMPLETE DENTURES; PROSTHESES; SUCCESS; RATINGS; STATE;
D O I
10.11607/jomi.6980
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: This cohort study evaluated patient satisfaction for maxillary implant-retained overdentures (IODs) on two implants up to 4 years and assessed the treatment effect over time. Materials and Methods: Patients encountering problems with their conventional dentures were included and received maxillary IODs on two titanium-zirconium implants and ball anchors in the canine area. Patient satisfaction was assessed using the oral health impact profile (OHIP-20E) questionnaires both for dentures and IODs. Two months after insertion of IODs (baseline), the patients chose the preferred overdenture design with full or reduced palatal coverage. OHIP-20E questionnaires were followed according to the individual choice at 1 and 4 years, and outcomes were compared with baseline. Results: Sixteen out of 21 patients were evaluated at a mean follow-up of 4 years (range: 2.4 to 4.8 years). There was no significant difference in the OHIP domains for IODs at 1 year (OHIP-total-1y: 9.5, SD: 13.0) and 4 years (OHIP-total-4y : 14.2, SD: 19.1) compared with baseline (OHIP-total-BL: 12.4, SD: 14.7). Patients were most satisfied with social disability both for IODs (OHIP-BL : 6.0, SD: 7.6; OHIP-1y : 3.4, SD: 5.4; OHIP-4y : 5.7, SD: 9.5) and dentures (OHIP-CD-old : 28, SD: 29.7; OHIP-CD-new : 25.4, SD: 28.67). Patients were least satisfied with functional limitation both for IODs (OHIP-BL : 6.0, SD: 7.6; OHIP-1y : 3.4, SD: 5.4; OHIP-4y : 5.7, SD: 9.5) and dentures (OHIP-CD-old : 28, SD: 29.7; OHIP-CD-new : 25.4, SD: 28.67). Conclusion: Patient satisfaction with maxillary lODs on two implants did not change from baseline to 4 years and was high at 4 years of function.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 50 条
  • [41] Changes in stair ascent biomechanics two to eight years after ACL reconstruction are associated with patient-reported outcomes
    Fischer, Arielle G.
    Erhart-Hledik, Jennifer C.
    Chu, Constance R.
    Asay, Jessica L.
    Andriacchi, Thomas P.
    GAIT & POSTURE, 2019, 69 : 91 - 95
  • [42] Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials
    Sholter, Dalton
    Wu, Jianmin
    Jia, Bochao
    Zhang, Hong
    Griffing, Kirstin
    Birt, Julie
    Reis, Paulo Jorge Simoes
    Liu, Huaxiang
    Bingham, Clifton O., III
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 541 - 553
  • [43] Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination
    Strand, Vibeke
    Mease, Philip J.
    Maksabedian Hernandez, Ervant J.
    Stolshek, Bradley S.
    Liu, Lyrica X. H.
    Collier, David H.
    Kricorian, Gregory
    Merola, Joseph F.
    RMD OPEN, 2021, 7 (01):
  • [44] Associations between Social Support and Patient-Reported Outcomes in Patients Receiving Hemodialysis: Results from the TACcare Study
    Erickson, Sarah J.
    Yabes, Jonathan G.
    Han, Zhuoheng
    Roumelioti, Maria-Eleni
    Rollman, Bruce L.
    Weisbord, Steven D.
    Steel, Jennifer L.
    Unruh, Mark L.
    Jhamb, Manisha
    KIDNEY360, 2024, 5 (06): : 860 - 869
  • [45] Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
    Zhu, Andrew X.
    Nipp, Ryan D.
    Finn, Richard S.
    Galle, Peter R.
    Llovet, Josep M.
    Blanc, Jean-Frederic
    Okusaka, Takuji
    Chau, Ian
    Cella, David
    Girvan, Allicia
    Gable, Jonathon
    Bowman, Lee
    Wang, Chunxiao
    Hsu, Yanzhi
    Abada, Paolo B.
    Kudo, Masatoshi
    ESMO OPEN, 2020, 5 (04)
  • [46] PATIENT-REPORTED OUTCOMES (PROs) IN ROMANIAN TYPE 2 DIABETIC PATIENTS - RESULTS FROM A MULTICENTRE NATIONAL REGISTRY
    Alexe, Octavian
    Gainaru, Cristian
    Serafinceanu, Cristian
    Plesea-Condratovici, Alina
    Danciulescu-Miulescu, Rucsandra
    Plesea-Condratovici, Catalin
    INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE, 2015, : 76 - 88
  • [47] Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial
    Lee, Lauren J.
    Fahrbach, Jessie L.
    Nelson, Lauren M.
    McLeod, Lori D.
    Martin, Sherry A.
    Sun, Peter
    Weinstock, Ruth S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (02) : 157 - 166
  • [48] Clinical and patient-reported outcomes of implants placed in autogenous bone grafts and implants placed in native bone: A case-control study with a follow-up of 5-16 years
    Thoma, Daniel S.
    Maggetti, Ivano
    Waller, Tobias
    Hammerle, Christoph H. F.
    Jung, Ronald E.
    CLINICAL ORAL IMPLANTS RESEARCH, 2019, 30 (03) : 242 - 249
  • [49] Patient-reported outcomes in patients with primary immunodeficiency diseases in Japan: baseline results from a prospective observational study
    Kanegane, Hirokazu
    Ishimura, Masataka
    Kawai, Toshinao
    Okada, Satoshi
    Okamatsu, Nobuaki
    Go, Madoka
    Noto, Shinichi
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [50] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Strand, Vibeke
    Alemao, Evo
    Lehman, Thomas
    Johnsen, Alyssa
    Banerjee, Subhashis
    Ahmad, Harris A.
    Mease, Philip J.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20